Key Record Dates
ClinicalTrials.gov Identifier: | NCT04071457 |
---|---|
Brief Title: | S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration (DRAMMATIC) |
First Submitted : | August 7, 2019 |
First Submitted that Met QC Criteria : | August 26, 2019 |
First Posted : | August 28, 2019 |
Last Update Submitted that Met QC Criteria : | September 29, 2020 |
Last Update Posted : | September 30, 2020 |